Elevance Health (ELV) Stock Forecast & Price Target $423.06 -5.83 (-1.36%) Closing price 04/7/2025 03:59 PM EasternExtended Trading$465.50 +42.44 (+10.03%) As of 09:01 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Elevance Health - Analysts' Recommendations and Stock Price Forecast (2025) How MarketBeat Calculates Price Target and Consensus Rating MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Consensus Rating Moderate BuyBased on 17 Analyst RatingsSell0Hold2Buy15 Based on 17 Wall Street analysts who have issued ratings for Elevance Health in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 17 analysts, 2 have given a hold rating, 14 have given a buy rating, and 1 has given a strong buy rating for ELV. Consensus Price Target $519.8122.87% Upside According to the 17 analysts' twelve-month price targets for Elevance Health, the average price target is $519.81. The highest price target for ELV is $649.00, while the lowest price target for ELV is $440.00. The average price target represents a forecasted upside of 22.87% from the current price of $423.06. Get the Latest News and Ratings for ELV and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Elevance Health and its competitors. Enter your email to sign up for newsletter Sign Up ELV Analyst Ratings Over TimeTypeCurrent Forecast4/8/24 to 4/8/251 Month Ago3/9/24 to 3/9/253 Months Ago1/9/24 to 1/8/251 Year Ago4/9/23 to 4/8/24Strong Buy1 Strong Buy rating(s)1 Strong Buy rating(s)1 Strong Buy rating(s)0 Strong Buy rating(s)Buy14 Buy rating(s)12 Buy rating(s)12 Buy rating(s)9 Buy rating(s)Hold2 Hold rating(s)3 Hold rating(s)2 Hold rating(s)1 Hold rating(s)Sell0 Sell rating(s)0 Sell rating(s)1 Sell rating(s)0 Sell rating(s)Consensus Price Target$519.81$517.03$536.53$569.00Forecasted Upside22.87% Upside26.23% Upside40.19% Upside11.57% UpsideConsensus RatingModerate BuyModerate BuyModerate BuyModerate Buy Remove Ads ELV Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History ELV Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Elevance Health Stock vs. The CompetitionTypeElevance HealthMedical CompaniesS&P 500Consensus Rating Score 2.94 2.82 2.53Consensus RatingModerate BuyModerate BuyModerate BuyPredicted Upside22.87% Upside18,047.66% Upside33.20% UpsideNews Sentiment RatingPositive NewsSee Recent ELV NewsPositive NewsPositive News Remove Ads Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails3/28/2025Sanford C. Bernstein3 of 5 stars Reiterated RatingOutperform ➝ Outperform3/17/2025Argus2 of 5 starsD. ToungSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy$450.00+6.71%1/28/2025Wells Fargo & Company3 of 5 starsStephen BaxterSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower TargetOverweight ➝ Overweight$483.00 ➝ $478.00+16.26%1/24/2025Cantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingSarah JamesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$485.00 ➝ $485.00+21.63%1/24/2025BarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingAndrew MokSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost TargetOverweight ➝ Overweight$501.00 ➝ $512.00+28.77%1/22/2025StephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingS. FidelSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOverweight ➝ Equal Weight$520.00 ➝ $440.00+12.98%1/6/2025Truist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy rating Lower TargetBuy ➝ Buy$520.00 ➝ $480.00+29.19%11/5/2024MizuhoSubscribe to MarketBeat All Access for the recommendation accuracy rating Lower TargetOutperform ➝ Outperform$585.00 ➝ $505.00+21.18%10/23/2024Morgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy rating Lower TargetOverweight ➝ Overweight$643.00 ➝ $551.00+31.24%10/21/2024TD CowenSubscribe to MarketBeat All Access for the recommendation accuracy rating Lower TargetBuy ➝ Buy$589.00 ➝ $484.00+12.56% Get the Latest News and Ratings for ELV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Elevance Health and its competitors with MarketBeat's FREE daily newsletter. 10/18/2024Raymond JamesSubscribe to MarketBeat All Access for the recommendation accuracy ratingSarah JamesSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Target$485.00+12.18%10/18/2024UBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating Lower TargetBuy ➝ Buy$605.00 ➝ $555.00+28.06%10/18/2024Royal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy rating Lower TargetOutperform ➝ Outperform$585.00 ➝ $478.00+9.02%7/18/2024Bank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy rating Reiterated RatingBuy ➝ Neutral$646.00 ➝ $530.00+1.89%5/30/2024Baird R WSubscribe to MarketBeat All Access for the recommendation accuracy ratingM. HaSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy5/30/2024JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetOverweight ➝ Overweight$628.00 ➝ $631.00+24.00%5/30/2024Robert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy rating Initiated CoverageOutperform$649.00+28.38%4/19/2024Jefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetBuy ➝ Buy$602.00 ➝ $604.00+15.01%7/12/2023Wolfe ResearchSubscribe to MarketBeat All Access for the recommendation accuracy rating DowngradeOutperform ➝ Peer Perform4/27/202322nd Century GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating Reiterated RatingUpgrade4/21/2023Loop CapitalSubscribe to MarketBeat All Access for the recommendation accuracy rating Lower TargetBuy$565.00 ➝ $550.00+20.90%4/20/2023Deutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the recommendation accuracy rating Boost Target$571.00 ➝ $575.00+25.73%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 09:02 AM ET. ELV Forecast - Frequently Asked Questions What is Elevance Health's forecast for 2025? According to the research reports of 17 Wall Street equities research analysts, the average twelve-month stock price forecast for Elevance Health is $519.81, with a high forecast of $649.00 and a low forecast of $440.00. Should I buy or sell Elevance Health stock right now? 17 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Elevance Health in the last twelve months. There are currently 2 hold ratings, 14 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" ELV shares. Does Elevance Health's stock price have much upside? According to analysts, Elevance Health's stock has a predicted upside of 22.87% based on their 12-month stock forecasts. Has Elevance Health been upgraded or downgraded by Wall Street analysts recently? Over the previous 90 days, Elevance Health's stock had 1 upgrade and 1 downgrade by analysts. What analysts cover Elevance Health? Elevance Health has been rated by research analysts at Argus, Barclays, Cantor Fitzgerald, Sanford C. Bernstein, Stephens, and Wells Fargo & Company in the past 90 days. Do Wall Street analysts like Elevance Health more than its competitors? Analysts like Elevance Health more than other "medical" companies. The consensus rating score for Elevance Health is 2.94 while the average consensus rating score for "medical" companies is 2.82. Learn more on how ELV compares to other companies. Stock Forecasts and Research Tools Related Companies CI Stock Forecast CNC Stock Forecast HUM Stock Forecast MOH Stock Forecast UNH Stock Forecast ALHC Stock Forecast OSCR Stock Forecast CLOV Stock Forecast TRUP Stock Forecast NEUE Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter This page (NYSE:ELV) was last updated on 4/8/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored**Breaking NEWS* This Company Starts To Rally As it Reduces $20 Million in Debt**Breaking NEWS* This Company Starts To Rally As it Reduces $20 Million in Debt Discover why Notable Names ...Huge Alerts | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredWill the U.S. military protect this $10B gold mine?You don’t need the gold price to move another inch for this company to potentially re-rate several hundred per...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredThese obscure companies are Trump’s favorites?Ten investments secretly owned by Trump’s biggest backers. Ten investments intrinsically tied to the polici...Porter & Company | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elevance Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elevance Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ELV Stock Free ELV Stock Alerts